Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial by Sáez-Llorens, Xavier, MD, Clemens, Ralf, MD, Leroux-Roels, Geert, MD, Jimeno, José, MD, Clemens, Sue Ann Costa, MD, Weldon, William C, PhD, Oberste, M Steven, PhD, Molina, Natanael, PharmD, Bandyopadhyay, Ananda S, Dr

Get full text